The safety and efficacy of dasatinib plus nivolumab in patients with previously treated chronic myeloid leukemia: results from a phase 1b dose-escalation study.
Joaquin Martinez LopezMohamed El MissiryKimmo PorkkaRebecca B KlisovicDominik WolfLambert BusqueJuan Carlos Carlos Hernández-BoludaRene SwaninkPatricia Martin RegueiraJeffrey H LiptonPublished in: Leukemia & lymphoma (2021)